Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: A randomized, double-blind, placebo-controlled trial

Pain Physician

Volumn 16, Issue 5, 2013, Pages 553-562

  Matthey, Alain ^a   Cedraschi, Christine ^a,b   Piguet, Valerie ^a   Besson, Marie ^a   Chabert, Jocelyne ^a   Daali, Youssef ^d   Courvoisier, Delphine ^a   Montagne, Agnes ^c   Dayer, Pierre ^a   Desmeules, Jules ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c CRD   (France)

^d Pierre Fabre Médicament ^*

Author keywords

5 HT noradrenaline re uptake inhibitor; Chronic pain; Descending noxious inhibitory controls; Dual reuptake inhibitor; Fibromyalgia; Fibromyalgia impact questionnaires; Milnacipran; Patient global impression of change; Quantitative sensory testing; Spinal nociceptive flexion reflex

Indexed keywords

MILNACIPRAN; PLACEBO; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR;

ADULT; ANALGESIC ACTIVITY; ARTICLE; BECK DEPRESSION INVENTORY; BLOOD PRESSURE; CONSTIPATION; CONTROLLED STUDY; COPING STRATEGY QUESTIONNAIRE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; HEART RATE; HOT FLUSH; HUMAN; HYPERHIDROSIS; MAJOR CLINICAL STUDY; NOCICEPTIVE FLEXION REFLEX R III THRESHOLD; PAIN ASSESSMENT; PAIN THRESHOLD; PATIENT COMPLIANCE; PATIENT GLOBAL IMPRESSION OF CHANGE; PHARMACODYNAMICS; PHASE 2 CLINICAL TRIAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF REPORT; SHORT FORM 36; SIDE EFFECT; SPINAL PAIN; STATE TRAIT ANXIETY INVENTORY; VISUAL ANALOG SCALE;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; CYCLOPROPANES; DOUBLE-BLIND METHOD; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; SPINAL DISEASES; TREATMENT OUTCOME;

EID: 84884682927     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Smith HS, Harris R, Clauw D. Fibromyalgia: An afferent processing disorder leading to a complex pain generalized syndrome. Pain Physician 2011; 14:E217-245.
2. Smith BW, Tooley EM, Montague EQ, Robinson AE, Cosper CJ, Mullins PG. Habituation and sensitization to heat and cold pain in women with fibromyalgia and healthy controls. Pain 2008; 140:420-428.
3. Staud R, Vierck CJ, Robinson ME, Price DD. Spatial summation of heat pain within and across dermatomes in fibromyalgia patients and pain-free subjects. Pain 2004; 111:342-350.
4. Desmeules JA, Cedraschi C, Rapiti E, Baumgartner E, Finckh A, Cohen P, Dayer P, Vischer TL. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 2003; 48:1420-1429.
5. Petzke F, Clauw DJ, Ambrose K, Khine A, Gracely RH. Increased pain sensitivity in fibromyalgia: Effects of stimulus type and mode of presentation. Pain 2003; 105:403-413.
6. Burgmer M, Pogatzki-Zahn E, Gaubitz M, Wessoleck E, Heuft G, Pfleiderer B. Altered brain activity during pain processing in fibromyalgia. Neuroimage 2009; 44:502-508.
7. Staud R, Bovee CE, Robinson ME, Price DD. Cutaneous C-fiber pain abnormalities of fibromyalgia patients are specifically related to temporal summation. Pain 2008; 139:315-323.
8. Staud R, Robinson ME, Price DD. Temporal summation of second pain and its maintenance are useful for characterizing widespread central sensitization of fibromyalgia patients. J Pain 2007; 8:893-901.
9. Jensen KB, Kosek E, Petzke F, Carville S, Fransson P, Marcus H, Williams SC, Choy E, Giesecke T, Mainguy Y, Gracely R, Ingvar M. Evidence of dysfunctional pain inhibition in fibromyalgia reflected in rACC during provoked pain. Pain 2009; 144:95-100.
10. Guedj E, Taieb D, Cammilleri S, Lussato D, de Laforte C, Niboyet J, Mundler O. 99mTcECD brain perfusion SPECT in hyperalgesic fibromyalgia. Eur J Nucl Med Mol Imaging 2007; 34:130-134.
11. Nijs J, Crombez G, Meeus M, Knoop H, Damme SV, Cauwenbergh V, Bleijenberg G. Pain in patients with chronic fatigue syndrome: Time for specific pain treatment? Pain Physician 2012; 15:E677-686.
12. Nijs J, Kosek E, Van Oosterwijck J, Meeus M. Dysfunctional endogenous analgesia during exercise in patients with chronic pain: To exercise or not to exercise? Pain Physician 2012; 15:ES205-213.
13. Silverman S, Dukes EM, Johnston SS, Brandenburg NA, Sadosky A, Huse DM. The economic burden of fibromyalgia: Comparative analysis with rheumatoid arthritis. Curr Med Res Opin 2009; 25:829-840.
14. Arnold LM, Gendreau RM, Palmer RH, Gendreau JF, Wang Y. Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: Results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2010; 62:2745-2756.
15. Goldenberg DL, Clauw DJ, Palmer RH, Mease P, Chen W, Gendreau RM. Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, doubleblind, monotherapy 6-month extension study. Pain Med 2010; 11:180-194.
16. Mease PJ, Clauw DJ, Gendreau RM, Rao SG, Kranzler J, Chen W, Palmer RH. The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol 2009; 36:398-409.
17. Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y. Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 2008;30:1988-2004.
18. Branco JC, Zachrisson O, Perrot S, Mainguy Y. A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia. J Rheumatol 2010; 37:851-859.
19. Banic B, Petersen-Felix S, Andersen OK, Radanov BP, Villiger PM, ArendtNielsen L, Curatolo M. Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia. Pain 2004; 107:7-15.
20. Sandrini G, Serrao M, Rossi P, Romaniello A, Cruccu G, Willer JC. The lower limb flexion reflex in humans. Prog Neurobiol 2005; 77:353-395.
21. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam A, Farber SJ, Fiechtner JJ, Francklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33:160-172.
22. Arendt-Nielsen L, Brennum J, Sindrup S, Bak P. Electrophysiological and psychophysical quantification of temporal summation in the human nociceptive system. Eur J Appl Physiol Occup Physiol 1994; 68:266-273.
23. Willer JC. Nociceptive flexion reflexes as a tool for pain research in man. Adv Neurol 1983; 39:809-827.
24. Willer JC, Le Bars D, De Broucker T. Diffuse noxious inhibitory controls in man: Involvement of an opioidergic link. Eur J Pharmacol 1990; 182:347-355.
25. Cruccu G, Anand P, Attal N, Garcia-Larrea L, Haanpaa M, Jorum E, Serra J, Jensen TS. EFNS guidelines on neuropathic pain assessment. Eur J Neurol 2004; 11:153-162.
26. Bouhassira D, Le Bars D, Bolgert F, Laplane D, Willer JC. Diffuse noxious inhibitory controls in humans: A neurophysiological investigation of a patient with a form of Brown-Sequard syndrome. Ann Neurol 1993; 34:536-543.
27. Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). II. Lack of effect on non-convergent neurones, supraspinal involvement and theoretical implications. Pain 1979; 6:305-327.
28. Willer JC, Boureau F, Albe-Fessard D. Supraspinal influences on nociceptive flexion reflex and pain sensation in man. Brain Res 1979; 179:61-68.
29. Claus D, Hilz MJ, Hummer I, Neundorfer B. Methods of measurement of thermal thresholds. Acta Neurol Scand 1987; 76:288-296.
30. Jamal GA, Weir AI, Hansen S, Ballantyne JP. An improved automated method for the measurement of thermal thresholds. 2. Patients with peripheral neuropathy. J Neurol Neurosurg Psychiatry 1985; 48:361-366.
31. Harris G, Rollman GB. The validity of experimental pain measures. Pain 1983; 17:369-376.
32. Garcia de Jalon PD, Harrison FJ, Johnson KI, Kozma C, Schnelle K. A modified cold stimulation technique for the evaluation of analgesic activity in human volunteers. Pain 1985; 22:183-189.
33. Petzke F, Khine A, Williams D, Groner K, Clauw DJ, Gracely RH. Dolorimetry performed at 3 paired tender points highly predicts overall tenderness. J Rheumatol 2001; 28:2568-2569.
34. Lautenschlager J, Seglias J, Bruckle W, Muller W. Comparisons of spontaneous pain and tenderness in patients with primary fibromyalgia. Clin Rheumatol 1991; 10:168-173.
35. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: Development and validation. J Rheumatol 1991; 18:728-733.
36. Perneger TV, Leplege A, Etter JF, Rougemont A. Validation of a French-language version of the MOS 36-Item Short Form Health Survey (SF-36) in young healthy adults. J Clin Epidemiol 1995; 48:1051-1060.
37. Finckh A, Morabia A, Deluze C, Vischer T. Validation of questionnaire-based response criteria of treatment efficacy in the fibromyalgia syndrome. Arthritis Care Res 1998; 11:116-123.
38. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571.